If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Humalog®
- Full Prescribing Information
Humalog® U-100 (insulin lispro injection)
100 units/mL - Full Prescribing Information
Humalog® U-200 (insulin lispro injection)
200 units/mL - Full Prescribing Information
Humalog® MIX50/50™ (50% insulin lispro protamine suspension 50% insulin lispro injection [rDNA origin])
100 units/mL - Full Prescribing Information
Humalog® MIX75/25™ (75% insulin lispro protamine suspension 25% insulin lispro injection [rDNA origin])
100 units/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
HUMALOG® (insulin lispro) 200 Units/mL: Transitioning From Insulin Lispro 100 Units/mL
When transitioning from insulin lispro 100 units/mL to insulin lispro 200 units/mL, no dose conversion is needed.
Do NOT perform dose conversion when using the IL-200 Pen.
The dose window shows the number of insulin units to be delivered and no conversion is needed.1
Therefore, a patient receiving 20 units of IL-100 and transitioning to the IL-200 Pen should dial the Pen to 20 units to administer the same 20-unit dose of insulin lispro.
Enclosed Prescribing Information
HUMALOG® (insulin lispro injection), for subcutaneous or intravenous use, Lilly
1. Humalog [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Glossary
IL-100 = Humalog® (insulin lispro injection) 100 units/mL
IL-200 = Humalog® (insulin lispro injection) 200 units/mL
Pen = KwikPen®
Date of Last Review: December 13, 2019
Contact Lilly
Call Us
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 8am - 7pm ET
